chronic granulomatous disease cgd also known syndrome chronic granulomatous disorder quie diverse group hereditary diseases certain cells immune system difficulty forming reactive oxygen compounds importantly superoxide radical due defective phagocyte nadph oxidase used kill certain ingested leads formation granulomas many cgd affects people united states new cases diagnosed condition first discovered series four boys minnesota named fatal granulomatosus childhood publication describing underlying cellular mechanism causes chronic granulomatous disease discovered research since time elucidated molecular mechanisms underlying bernard babior made key contributions linking defect superoxide production white blood cells cause disease xlinked form cgd first disease positional cloning used identify underlying genetic mutation classically patients chronic granulomatous disease recurrent bouts infection due decreased capacity immune system fight diseasecausing organisms recurrent infections acquire specific decreasing order frequencycitation needed people cgd diagnosed childhood usually age early diagnosis important since people placed antibiotics ward infections occur small groups cgd patients may also affected mcleod syndrome proximity two genes xchromosomecitation needed people cgd sometimes infected organisms usually cause disease people normal immune systems among common organisms cause disease cgd patients patients cgd usually resist infections catalasenegative bacteria susceptible catalasepositive bacteria catalase enzyme catalyzes breakdown hydrogen peroxide many organisms infections caused organisms lack catalase catalasenegative host cgd successfully able borrow hydrogen peroxide made organism use fight infections organisms catalase catalasepositive borrowing mechanism unsuccessful enzyme catalase first breaks hydrogen peroxide would borrowed organism therefore cgd patient hydrogen peroxide used make oxygen radicals fight infection leaving patient vulnerable infection catalasepositive bacteriacitation needed cases chronic granulomatous disease transmitted mutation x chromosome thus called xlinked affected gene x chromosome codes protein weight protein kda gp means glycoprotein cgd also transmitted autosomal recessive fashion via cyba affect phox proteins type mutation causes types cgd varied may deletions frameshift nonsense low level nadph cofactor required superoxide synthesis lead cgd reported women homozygous genetic defect causing dehydrogenase deficiency characterised reduced nadph phagocytes ie neutrophils macrophages require enzyme produce reactive oxygen species destroy bacteria ingested phagocytosis process known respiratory burst enzyme termed phagocyte nadph oxidase phox enzyme oxidizes nadph reduces molecular oxygen produce superoxide anions reactive oxygen species superoxide disproportionated peroxide molecular oxygen superoxide dismutase finally peroxide used myeloperoxidase oxidize chloride ions hypochlorite active component bleach toxic bacteria thus nadph oxidase critical phagocyte killing bacteria reactive oxygen speciescitation needed two mechanisms used phagocytes kill bacteria nitric oxide proteases loss rosmediated killing alone sufficient cause chronic granulomatous diseasecitation needed defects one four essential subunits phagocyte nadph oxidase phox cause cgd varying severity dependent defect known possible defects phox enzyme complex lead chronic granulomatous chronic granulomatous disease cgd suspected neutrophilfunction testing carried positive findings confirmed mutation due pseudogene conversion hence may detectable standard sequencing cases immunoblot gene dose determination may needed confirm infections caused pathogens commonly associated cgd prompt functional genetic screening neonatal early postnatal screening potentially affected children essential family history neutrophil function tests include nitroblue tetrazolium nbt reduction test dihydrorhodamine dhr test direct measurement superoxide production cytochrome c reduction assay dhr test usually preferred easy use objective able distinguish xlinked autosomal forms cgd furthermore allows detect genetic testing cgd diagnosed based abnormal neutrophil function tests genetic testing go next mentioned defect usually difficult identify genetically caused pseudogene conversion may missed typical sequencing studies case immunoblotting flow cytometry show absence prenatal testing particularly useful family member already diagnosed cgd test may performed analysis nadph oxidase activity neutrophils fetal samples amniotic fluid chorionic villi provides earlier reliable diagnosis families chronic granulomatous disease name genetically heterogeneous group immunodeficiencies core defect failure phagocytic cells kill organisms engulfed defects system enzymes produce free radicals toxic small molecules several types management chronic granulomatous disease revolves around two goals diagnose disease early antibiotic prophylaxis given keep infection occurring educate patient condition prompt treatment given infection occurscitation needed physicians often prescribe antibiotic trimethoprimsulfamethoxazole prevent bacterial drug also benefit sparing normal bacteria digestive tract fungal infection commonly prevented although newer drug type called voriconazole may use drug purpose still scientific investigationcitation needed interferon form interferon actimmune approved food drug administration prevention infection cgd shown reduce infections cgd patients decrease severity although exact mechanism still entirely understood ability give cgd patients immune function therefore greater ability fight infections therapy standard treatment cgd several hematopoietic stem cell transplantation matched donor curative although without significant currently studies detailing long term outcome chronic granulomatous disease modern treatment without treatment children often die first decade life increased severity xlinked cgd results decreased survival rate patients xlinked patients die cgdrelated causes age whereas autosomal recessive patients die age experience centers specializing care patients cgd suggests current mortality fallen cgd initially termed fatal granulomatous disease childhood patients rarely survived past first decade time routine use prophylactic antimicrobial agents average patient survives least cgd affects people united states new cases diagnosed chronic granulomatous disease affects people races however limited information prevalence outside united states one survey sweden reported incidence larger review studies europe suggested lower rate condition first described janeway reported five cases disease characterized fatal granulomatosus underlying cellular mechanism causes chronic granulomatous disease discovered research since time elucidated molecular mechanisms underlying use antibiotic prophylaxis surgical abscess drainage vaccination led term fatal dropped name disease children survived adulthoodcitation needed gene therapy currently studied possible treatment chronic granulomatous disease cgd wellsuited gene therapy since caused mutation single gene affects one body system hematopoietic system viruses used deliver normal gene rats mutation gene subsequently phagocytes rats able produce oxygen two human patients xlinked chronic granulomatous disease underwent gene therapy blood cell precursor stem cell transplantation bone marrow patients recovered cgd clearing preexisting infections demonstrating increased oxidase activity neutrophils however longterm complications efficacy therapy boy cgd treated great ormond street hospital london experimental gene therapy temporarily reversed cgd allowed overcome lifethreatening lung httpsenwikipediaorgwikichronicgranulomatousdisease